Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Canada House Opens its Door to Pharmadrug Inc.

Stockhouse Editorial
1 Comment| November 1, 2019

{{labelSign}}  Favorites
{{errorMessage}}

Canada House Wellness Group Inc. (CSE:CHV, OTC: SARSF, Forum) announced this week that its wholly owned subsidiary, Abba Medix Corp., has entered into a five-year supply agreement with Pharmadrug Production GmbH, a German EU GMP approved generic pharmaceutical manufacturer, and a subsidiary of Pharmadrug Inc. (CSE: BUZZ).

For more on this, click here.

On October 1st 2019, Abba Medix began selling its own premium medical-grade Abba-branded cannabis flower.


FULL DISCLOSURE: Canada House Wellness Group Inc. is a client of Stockhouse Publishing.



{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company